
The Securities and Exchange Commission (SEC) announced that it has named Austin Gerig as its Chief Data Officer. Dr. Gerig, currently Assistant Director of the Office of Data Science in the Division of Economic and Risk Analysis (DERA), will assume his new position on February 3.
The Chief Data Officer will help develop the SEC’s data management strategy and priorities, enable data analytics to support enforcement, examinations, and policymaking, and ensure that the agency collects only the data it needs to fulfill its mission and can effectively secure.
“I am pleased that Dr. Gerig has agreed to bring his broad experience in data strategy and management to this important new role for the Commission,” said Chairman Jay Clayton. “He is well suited to further our efforts to ensure there is a coherence between the information we collect and the information we need to carry out our mission. My colleagues at the Commission and I look forward to working with Austin as we strive to better both our use and our protection of data.”
Dr. Gerig has headed DERA’s Office of Data Science since September 2016, managing a team of data scientists, data engineers, financial economists, and research associates. He co-chairs the SEC’s Data Management Working Group and has served as the SEC’s representative on the Financial Stability Board’s Analytical Group on Vulnerabilities and its Financial Innovation Group. He began his SEC career in June 2014 as a financial economist in DERA.
Full Content: SEC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas